These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 2566882)

  • 1. Localization of dynorphin-induced neurotoxicity in rat spinal cord.
    Stewart P; Isaac L
    Life Sci; 1989; 44(20):1505-14. PubMed ID: 2566882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Correlation between motor paralysis and neurotoxicity induced by intrathecal dynorphin A (1-17) in rats].
    Cui CL; Wu LZ; Han JS
    Yao Xue Xue Bao; 1997; 32(2):85-9. PubMed ID: 11243205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrathecal dynorphin(1-13) results in an irreversible loss of the tail-flick reflex in rats.
    Caudle RM; Isaac L
    Brain Res; 1987 Dec; 435(1-2):1-6. PubMed ID: 2892573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynorphin A (1-13) potentiates dynorphin A (1-17) on loss of the tail-flick reflex after intrathecal injection in the rat.
    Qu ZX; Isaac L
    Brain Res; 1993 May; 610(2):340-3. PubMed ID: 8100473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A strychnine-sensitive site is involved in dynorphin-induced paralysis and loss of the tail-flick reflex.
    Stewart P; Isaac L
    Brain Res; 1991 Mar; 543(2):322-6. PubMed ID: 1676332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynorphin A-induced rat hindlimb paralysis and spinal cord injury are not altered by the kappa opioid antagonist nor-binaltorphimine.
    Long JB; Rigamonti DD; de Costa B; Rice KC; Martinez-Arizala A
    Brain Res; 1989 Sep; 497(1):155-62. PubMed ID: 2571391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of high intravenous doses of dynorphin A(1-13) on tail flick latency and central nervous system histology in rats.
    Pentel PR; Wananukul W; Hooke LP; Jones CR; Hatsukami D; Anderson WR; Lee NM
    Pharmacol Biochem Behav; 1995; 51(2-3):387-90. PubMed ID: 7667358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1-Aminocyclopropanecarboxylic acid protects against dynorphin A-induced spinal injury.
    Long JB; Skolnick P
    Eur J Pharmacol; 1994 Aug; 261(3):295-301. PubMed ID: 7813551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of dynorphin (1-13) on spinal reflexes in the rat.
    Caudle RM; Isaac L
    J Pharmacol Exp Ther; 1988 Aug; 246(2):508-13. PubMed ID: 2900326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MK-801 blocks dynorphin A (1-13)-induced loss of the tail-flick reflex in the rat.
    Isaac L; Van Zandt O'Malley T; Ristic H; Stewart P
    Brain Res; 1990 Oct; 531(1-2):83-7. PubMed ID: 1981166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurological dysfunction after intrathecal injection of dynorphin A (1-13) in the rat. I. Injection procedures modify pharmacological responses.
    Long JB; Mobley WC; Holaday JW
    J Pharmacol Exp Ther; 1988 Sep; 246(3):1158-66. PubMed ID: 2901486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hindlimb paralytic effects of prodynorphin-derived peptides following spinal subarachnoid injection in rats.
    Long JB; Martinez-Arizala A; Echevarria EE; Tidwell RE; Holaday JW
    Eur J Pharmacol; 1988 Aug; 153(1):45-54. PubMed ID: 2905665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulators of pain in the spinal cord.
    Jen MF; Lu CH; Huang L; Han JS
    NIDA Res Monogr; 1986; 75():457-60. PubMed ID: 2893278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel interaction between dynorphin(1-13) and an N-methyl-D-aspartate site.
    Caudle RM; Isaac L
    Brain Res; 1988 Mar; 443(1-2):329-32. PubMed ID: 2896056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-activity analysis of dynorphin A toxicity in spinal cord neurons: intrinsic neurotoxicity of dynorphin A and its carboxyl-terminal, nonopioid metabolites.
    Hauser KF; Knapp PE; Turbek CS
    Exp Neurol; 2001 Mar; 168(1):78-87. PubMed ID: 11170722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynorphin A (1-13) neurotoxicity in vitro: opioid and non-opioid mechanisms in mouse spinal cord neurons.
    Hauser KF; Foldes JK; Turbek CS
    Exp Neurol; 1999 Dec; 160(2):361-75. PubMed ID: 10619553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Competitive and non-competitive NMDA antagonists limit dynorphin A-induced rat hindlimb paralysis.
    Bakshi R; Faden AI
    Brain Res; 1990 Jan; 507(1):1-5. PubMed ID: 1967971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurological dysfunction after intrathecal injection of dynorphin A (1-13) in the rat. II. Nonopioid mechanisms mediate loss of motor, sensory and autonomic function.
    Long JB; Petras JM; Mobley WC; Holaday JW
    J Pharmacol Exp Ther; 1988 Sep; 246(3):1167-74. PubMed ID: 2901487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antinociception and paralysis induced by intrathecal dynorphin A.
    Herman BH; Goldstein A
    J Pharmacol Exp Ther; 1985 Jan; 232(1):27-32. PubMed ID: 2856940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynorphin A-induced rat spinal cord injury: evidence for excitatory amino acid involvement in a pharmacological model of ischemic spinal cord injury.
    Long JB; Rigamonti DD; Oleshansky MA; Wingfield CP; Martinez-Arizala A
    J Pharmacol Exp Ther; 1994 Apr; 269(1):358-66. PubMed ID: 7909561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.